•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A02340 Summary:

BILL NOA02340A
 
SAME ASSAME AS S04552-A
 
SPONSORMcDonald
 
COSPNSRSteck, Woerner, Walsh, Ra, Santabarbara, Griffin, Colton, Shimsky, Blankenbush, Durso, Hawley, McDonough, Manktelow, Buttenschon, Glick, Hevesi, Lunsford, Ramos, Giglio, Brown K, DeStefano, Norber, Gallahan, Sayegh, Jacobson
 
MLTSPNSR
 
Amd Art 13-F Art Head, §1399-aa, add Art 13-F §1399-mmm, Pub Health L
 
Prohibits the sale of kratom to individuals under the age of twenty-one; imposes a civil penalty of not more than five hundred dollars for the sale or provision of kratom to any person under the age of twenty-one.
Go to top

A02340 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A2340A
 
SPONSOR: McDonald
  TITLE OF BILL: An act to amend the public health law, in relation to the prohibition of the sale of kratom to individuals under the age of twenty-one   PURPOSE: This legislation will prevent the sale of kratom to individuals under 21.   SUMMARY OF PROVISIONS: Section 1. Changes title of section Section 2. Adds Kratom definition to the public health law Section 3. Amends the public health law to add the prohibition of the sale of kratom for those under the age of 21. Requires signage about the prohibition of kratom. Requires those buying kratom to show identifica- tion. Section 4. Requires commissioner of health to conduct a study relating to kratom. Section 5. Establishes the effective date   JUSTIFICATION: Kratom is an opioid like plant which has a stimulant or opioid-like effect. It is typically sold as tea leaves, powder or pill form for muscle relaxation, to fight fatigue, and as an antidepressant. Despite these many alleged medicinal benefits, the Drug Enforcement Adminis- tration lists it as a drug of concern with no medicinal value. Further- more, the Food and Drug Administration compares kratom to morphine in its risks for addiction, abuse and dependence. Several FDA studies are continuing to evaluate the scientific information on kratom but warns consumers to not use any products containing kratom until it is better understood. According to the Center for Disease Control, kratom was listed as the cause of death for 91 individuals out of 152 who tested positive for kratom between July 2016 and December 2017. This legislation is intended to help keep kratom out of the hands of children and young adults. Under this legislation, a person who sells kratom to individuals under 21 will face up to a $500 fine. Sales of kratom have already been banned in Thailand, Alabama, Arkansas, Indiana, Vermont, Rhode Island, Washington DC and Wisconsin. Tennessee and Suffolk County also has a ban for sales under 21. New Hampshire and Illinois bans the sale under 18. This bill does not seek an across-the- board ban but is consistent with measures taken with items such as Mari- juana. New York needs to protect individuals from this substance by banning the sale of this substance for those under 21.   PRIOR LEGISLATIVE HISTORY: 2021: referred to health/reported 2021-22: referred to ways and means 23-2024: Steck (A4376)   FISCAL IMPLICATIONS: To be determined.   EFFECTIVE DATE: Immediately.
Go to top